TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

Launched by BIOLOGISCHE HEILMITTEL HEEL GMBH · Feb 9, 2010

Keywords

ClinConnect Summary

Study objective is the confirmatory proof of efficacy for Traumeel® S topical treatment, both ointment and gel, as compared to diclofenac topical treatment for patients with ankle sprain. In addition tolerability/safety of both drug preparations is to be compared, so that the benefit-risk relation can be determined.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Athletes with an acute unilateral ankle sprain of the lateral ligaments of the ankle joint both male and female
• • Moderate (30-60 mm) to severe (\>60 mm) pain according to the patient's assessment of ankle pain visual analogue scale (VAS) on weight bearing, unable to perform normal training / sports activities
• • 18 - 40 years of age
• • injury occurred within 24 hours of the first dose of study medication
• • Willing and able to give written informed consent
• • Available for the duration of the study
• Exclusion Criteria:
• • Similar injury affecting the same joint within the past 6 months
• • bilateral ankle injury
• • bed rest, hospitalization, surgery use of a non-removable rigid cast
• • Clinically important abnormality for screening laboratory tests
• • Debilitating acute or chronic illness
• • Use of corticosteroids in the previous 8 weeks, any analgesics in the previous 6 hours, or 24 hours in case of long-acting NSAID, COX-2 specific inhibitors, or tramadol
• • History of sensitivity to any component of the study drugs
• • Unwilling or unable to comply with all the requirements of the protocol
• • Participation in other studies within 4 weeks prior to study entry and or during the study participation
• • Current substance or alcohol abuse that in the opinion of the investigator would interfere with compliance or with interpretation of the study result